UBS Group’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $685K | Buy |
263,526
+110,675
| +72% | +$288K | ﹤0.01% | 4615 |
|
|
2025
Q1 | $290K | Sell |
152,851
-10,805
| -7% | -$20.5K | ﹤0.01% | 5054 |
|
|
2024
Q4 | $237K | Buy |
163,656
+98,256
| +150% | +$142K | ﹤0.01% | 5159 |
|
|
2024
Q3 | $120K | Buy |
65,400
+15,172
| +30% | +$27.9K | ﹤0.01% | 5044 |
|
|
2024
Q2 | $50.2K | Sell |
50,228
-59,983
| -54% | -$60K | ﹤0.01% | 5543 |
|
|
2024
Q1 | $218K | Buy |
110,211
+7,663
| +7% | +$15.2K | ﹤0.01% | 4659 |
|
|
2023
Q4 | $160K | Buy |
102,548
+43,503
| +74% | +$67.9K | ﹤0.01% | 4722 |
|
|
2023
Q3 | $116K | Sell |
59,045
-3,417
| -5% | -$6.73K | ﹤0.01% | 4627 |
|
|
2023
Q2 | $199K | Buy |
62,462
+54,780
| +713% | +$174K | ﹤0.01% | 4451 |
|
|
2023
Q1 | $25.1K | Sell |
7,682
-4,137
| -35% | -$13.5K | ﹤0.01% | 5822 |
|
|
2022
Q4 | $59.5K | Buy |
11,819
+4,591
| +64% | +$23.1K | ﹤0.01% | 5448 |
|
|
2022
Q3 | $16K | Hold |
7,228
| – | – | ﹤0.01% | 6582 |
|
|
2022
Q2 | $19K | Hold |
7,228
| – | – | ﹤0.01% | 5897 |
|
|
2022
Q1 | $10K | Hold |
7,228
| – | – | ﹤0.01% | 7344 |
|
|
2021
Q4 | $23K | Buy |
+7,228
| New | +$23K | ﹤0.01% | 6557 |
|